Perfil
Bent U.
Frandsen currently works at ExpreS2ion Biotechnologies ApS, as Chief Executive Officer and Expres2ion Biotech Holding AB, as Chief Executive Officer from 2019.
Mr. Frandsen also formerly worked at Adaptvac ApS, as Director and NsGene A, as Vice President-Business Development.
Mr. Frandsen received his graduate degree in 1993 from Copenhagen Business School.
Cargos activos de Bent Frandsen
| Empresas | Cargo | Inicio |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Director Ejecutivo | 20/12/2019 |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Director Ejecutivo | - |
Antiguos cargos conocidos de Bent Frandsen.
| Empresas | Cargo | Fin |
|---|---|---|
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders | Corporate Officer/Principal | - |
Adaptvac ApS
Adaptvac ApS BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines | Director/Miembro de la Junta | - |
Formación de Bent Frandsen.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NsGene A/S
NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders | Health Technology |
ExpreS2ion Biotechnologies ApS
ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells | Health Technology |
Expres2ion Biotech Holding AB
Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
Adaptvac ApS
Adaptvac ApS BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines | Health Technology |
- Bolsa de valores
- Insiders
- Bent Frandsen
















